Familial dysautonomia is a genetic disorder that affects the development and survival of certain nerve cells. The disorder disturbs cells in the autonomic nervous system, which controls involuntary actions such as digestion, breathing, production of tears, and the regulation of blood pressure and body temperature. It also affects the sensory nervous system, which controls activities related to the senses, such as taste and the perception of pain, heat, and cold. Familial dysautonomia is also called hereditary sensory and autonomic neuropathy, type III.
Problems related to this disorder first appear during infancy. Early signs and symptoms include poor muscle tone (hypotonia), feeding difficulties, poor growth, lack of tears, frequent lung infections, and difficulty maintaining body temperature. Older infants and young children with familial dysautonomia may hold their breath for prolonged periods of time, which may cause a bluish appearance of the skin or lips (cyanosis) or fainting. This breath-holding behavior usually stops by age 6. Developmental milestones, such as walking and speech, are usually delayed, although some affected individuals show no signs of developmental delay.
Additional signs and symptoms in school-age children include bed wetting, episodes of vomiting, reduced sensitivity to temperature changes and pain, poor balance, abnormal curvature of the spine (scoliosis), poor bone quality and increased risk of bone fractures, and kidney and heart problems. Affected individuals also have poor regulation of blood pressure. They may experience a sharp drop in blood pressure upon standing (orthostatic hypotension), which can cause dizziness, blurred vision, or fainting. They can also have episodes of high blood pressure when nervous or excited, or during vomiting incidents. About one-third of children with familial dysautonomia have learning disabilities, such as a short attention span, that require special education classes. By adulthood, affected individuals often have increasing difficulties with balance and walking unaided. Other problems that may appear in adolescence or early adulthood include lung damage due to repeated infections, impaired kidney function, and worsening vision due to the shrinking size (atrophy) of optic nerves, which carry information from the eyes to the brain.
Familial dysautonomia occurs primarily in people of Ashkenazi (central or eastern European) Jewish descent. It affects about 1 in 3,700 individuals in Ashkenazi Jewish populations. Familial dysautonomia is extremely rare in the general population.
Mutations in the ELP1 gene cause familial dysautonomia. The ELP1 gene provides instructions for making a protein that is found in a variety of cells throughout the body, including brain cells.
Nearly all individuals with familial dysautonomia have two copies of the same ELP1 gene mutation in each cell. This mutation can disrupt how information in the ELP1 gene is pieced together to make a blueprint for the production of ELP1 protein. As a result of this error, a reduced amount of normal ELP1 protein is produced. This mutation behaves inconsistently, however. Some cells produce near normal amounts of the protein, and other cells—particularly brain cells—have very little of the protein. Critical activities in brain cells are probably disrupted by reduced amounts or the absence of ELP1 protein, leading to the signs and symptoms of familial dysautonomia.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
5. Other Names for This Condition
- HSAN Type III
- Riley-Day Syndrome
The entry is from https://medlineplus.gov/genetics/condition/familial-dysautonomia
- Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY. Familial dysautonomia is caused by mutations of the IKAP gene. Am J HumGenet. 2001 Mar;68(3):753-8.
- Axelrod FB, Hilz MJ. Inherited autonomic neuropathies. Semin Neurol. 2003Dec;23(4):381-90. Review.
- Axelrod FB. Familial dysautonomia. Muscle Nerve. 2004 Mar;29(3):352-63.Review.
- Axelrod FB. Hereditary sensory and autonomic neuropathies. Familialdysautonomia and other HSANs. Clin Auton Res. 2002 May;12 Suppl 1:I2-14. Review.
- Carroll MS, Kenny AS, Patwari PP, Ramirez JM, Weese-Mayer DE. Respiratory and cardiovascular indicators of autonomic nervous system dysregulation in familialdysautonomia. Pediatr Pulmonol. 2012 Jul;47(7):682-91. doi: 10.1002/ppul.21600.
- Elkayam L, Matalon A, Tseng CH, Axelrod F. Prevalence and severity of renaldisease in familial dysautonomia. Am J Kidney Dis. 2006 Nov;48(5):780-6.
- Gold-von Simson G, Axelrod FB. Familial dysautonomia: update and recentadvances. Curr Probl Pediatr Adolesc Health Care. 2006 Jul;36(6):218-37. Review.
- Norcliffe-Kaufmann L, Axelrod FB, Kaufmann H. Developmental abnormalities,blood pressure variability and renal disease in Riley Day syndrome. J HumHypertens. 2013 Jan;27(1):51-5. doi: 10.1038/jhh.2011.107.
- Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, LiebertCB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M,Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF. Tissue-specificexpression of a splicing mutation in the IKBKAP gene causes familialdysautonomia. Am J Hum Genet. 2001 Mar;68(3):598-605.
- Slaugenhaupt SA, Gusella JF. Familial dysautonomia. Curr Opin Genet Dev. 2002 Jun;12(3):307-11. Review.
- Please check and comment entries here.